The coronavirus disease 2019(COVID-19)pandemic has become a global burden,further exacerbating the occurrence of risk events in cancer patients.The high risk of death from pancreatic cancer makes it one of the most le...The coronavirus disease 2019(COVID-19)pandemic has become a global burden,further exacerbating the occurrence of risk events in cancer patients.The high risk of death from pancreatic cancer makes it one of the most lethal malignancies.Recently,it was reported in the World Journal of Gastrointestinal Oncology that COVID-19 influences pancreatic cancer progression via the lung–gut–pancreatic axis,and the authors provided insights into the intrinsic crosstalk mechanisms in which the gut microbiota is involved,the characteristics and effects of inflammatory factors,and immunotherapeutic strategies for treating both diseases.Here,we review the latest cutting-edge researches in the field of the lung-gut-pancreatic axis and discuss future perspectives to address the severe survival challenges posed by the COVID-19 pandemic in patients with pancreatic cancer.展开更多
文摘The coronavirus disease 2019(COVID-19)pandemic has become a global burden,further exacerbating the occurrence of risk events in cancer patients.The high risk of death from pancreatic cancer makes it one of the most lethal malignancies.Recently,it was reported in the World Journal of Gastrointestinal Oncology that COVID-19 influences pancreatic cancer progression via the lung–gut–pancreatic axis,and the authors provided insights into the intrinsic crosstalk mechanisms in which the gut microbiota is involved,the characteristics and effects of inflammatory factors,and immunotherapeutic strategies for treating both diseases.Here,we review the latest cutting-edge researches in the field of the lung-gut-pancreatic axis and discuss future perspectives to address the severe survival challenges posed by the COVID-19 pandemic in patients with pancreatic cancer.
